“Stable” vs. “silent progressive multiple sclerosis”: a real-world retrospective clinical imaging Brazilian study

BACKGROUND: Clinical and imaging are required to characterize activity and progression in MS. The parameters for activity are well defined but not those for progression. The ideal aim for long-term treatment is that neither clinical nor imaging signs of disease should be present, and also no brain a...

Descripción completa

Detalles Bibliográficos
Autores principales: FIGUEIRA, Gustavo Medeiros Andrade, SOARES, Paula Vallegas, da SILVEIRA, Raquel Custodio, FIGUEIRA, Fernando Faria Andrade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academia Brasileira de Neurologia - ABNEURO 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173213/
https://www.ncbi.nlm.nih.gov/pubmed/35195220
http://dx.doi.org/10.1590/0004-282X-ANP-2020-0234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173213/
https://www.ncbi.nlm.nih.gov/pubmed/35195220
http://dx.doi.org/10.1590/0004-282X-ANP-2020-0234

Ejemplares similares